OSI Systems (NASDAQ:OSIS) Releases FY 2024 Earnings Guidance

OSI Systems (NASDAQ:OSIS) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 8.070- for the period, compared to the consensus estimate of 8.020. The company issued revenue guidance of $1.5 billion-, compared to the consensus revenue estimate of $1.5 billion. OSI Systems also updated its FY24 guidance to above $8.07 EPS.

OSI Systems Price Performance

Shares of NASDAQ:OSIS traded up $0.67 during midday trading on Friday, reaching $134.82. The company’s stock had a trading volume of 103,502 shares, compared to its average volume of 93,558. OSI Systems has a fifty-two week low of $102.02 and a fifty-two week high of $144.11. The company has a market capitalization of $2.30 billion, a P/E ratio of 20.46, a P/E/G ratio of 1.58 and a beta of 0.98. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.43 and a quick ratio of 0.80. The business’s fifty day simple moving average is $135.68 and its 200-day simple moving average is $127.40.

OSI Systems (NASDAQ:OSIS) last announced its earnings results on Thursday, April 25th. The technology company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $2.11 by $0.05. The company had revenue of $405.41 million during the quarter, compared to analyst estimates of $401.99 million. OSI Systems had a return on equity of 17.35% and a net margin of 8.31%. The firm’s quarterly revenue was up 33.8% compared to the same quarter last year. During the same period last year, the company posted $1.49 earnings per share. As a group, equities research analysts expect that OSI Systems will post 8.03 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

OSIS has been the subject of a number of research reports. StockNews.com upgraded OSI Systems from a hold rating to a buy rating in a research report on Friday, April 19th. Roth Mkm lifted their price objective on OSI Systems from $169.00 to $172.00 and gave the stock a buy rating in a research report on Friday.

Insider Activity

In other news, General Counsel Victor S. Sze sold 15,000 shares of OSI Systems stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $131.22, for a total transaction of $1,968,300.00. Following the transaction, the general counsel now owns 78,116 shares in the company, valued at approximately $10,250,381.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other OSI Systems news, General Counsel Victor S. Sze sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $131.22, for a total transaction of $1,968,300.00. Following the transaction, the general counsel now owns 78,116 shares of the company’s stock, valued at approximately $10,250,381.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Deepak Chopra sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $129.11, for a total value of $2,582,200.00. Following the transaction, the chief executive officer now directly owns 468,615 shares in the company, valued at approximately $60,502,882.65. The disclosure for this sale can be found here. Insiders have sold 50,000 shares of company stock worth $6,503,650 in the last 90 days. Corporate insiders own 5.60% of the company’s stock.

About OSI Systems

OSI Systems, Inc designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.